Skeletal muscle desmin alterations following revascularization in peripheral artery disease claudicants
- PMID: 38824194
- PMCID: PMC11144188
- DOI: 10.1038/s41598-024-63626-3
Skeletal muscle desmin alterations following revascularization in peripheral artery disease claudicants
Abstract
Peripheral artery disease (PAD) is characterized by varying severity of arterial stenosis, exercise induced claudication, malperfused tissue precluding normal healing and skeletal muscle dysfunction. Revascularization interventions improve circulation, but post-reperfusion changes within the skeletal muscle are not well characterized. This study investigates if revascularization enhanced hemodynamics increases walking performance with concurrent improvement of mitochondrial function and reverses abnormal skeletal muscle morphological features that develop with PAD. Fifty-eight patients completed walking performance testing and muscle biopsy before and 6 months after revascularization procedures. Muscle fiber morphology, desmin structure, and mitochondria respiration assessments before and after the revascularization were evaluated. Revascularization improved limb hemodynamics, walking function, and muscle morphology. Qualitatively not all participants recovered normal structural architecture of desmin in the myopathic myofibers after revascularization. Heterogenous responses in the recovery of desmin structure following revascularization may be caused by other underlying factors not reversed with hemodynamic improvements. Revascularization interventions clinically improve patient walking ability and can reverse the multiple subcellular functional and structural abnormalities in muscle cells. Further study is needed to characterize desmin structural remodeling with improvements in skeletal muscle morphology and function.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11144188/bin/41598_2024_63626_Fig1_HTML.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11144188/bin/41598_2024_63626_Fig2_HTML.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11144188/bin/41598_2024_63626_Fig3_HTML.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/11144188/bin/41598_2024_63626_Fig4_HTML.gif)
Similar articles
-
The Role of Mitochondrial Function in Peripheral Arterial Disease: Insights from Translational Studies.Int J Mol Sci. 2021 Aug 6;22(16):8478. doi: 10.3390/ijms22168478. Int J Mol Sci. 2021. PMID: 34445191 Free PMC article. Review.
-
Skeletal Muscle Pathology in Peripheral Artery Disease: A Brief Review.Arterioscler Thromb Vasc Biol. 2020 Nov;40(11):2577-2585. doi: 10.1161/ATVBAHA.120.313831. Epub 2020 Sep 17. Arterioscler Thromb Vasc Biol. 2020. PMID: 32938218 Free PMC article. Review.
-
Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease.Am J Physiol Heart Circ Physiol. 2020 Aug 1;319(2):H456-H467. doi: 10.1152/ajpheart.00235.2020. Epub 2020 Jul 24. Am J Physiol Heart Circ Physiol. 2020. PMID: 32706261 Clinical Trial.
-
Near infrared spectroscopy-guided exercise training for claudication in peripheral arterial disease.Eur J Prev Cardiol. 2019 Mar;26(5):471-480. doi: 10.1177/2047487318795192. Epub 2018 Aug 28. Eur J Prev Cardiol. 2019. PMID: 30152245 Clinical Trial.
-
Abnormal accumulation of desmin in gastrocnemius myofibers of patients with peripheral artery disease: associations with altered myofiber morphology and density, mitochondrial dysfunction and impaired limb function.J Histochem Cytochem. 2015 Apr;63(4):256-69. doi: 10.1369/0022155415569348. Epub 2015 Jan 9. J Histochem Cytochem. 2015. PMID: 25575565 Free PMC article.
References
-
- Pipinos II, Juadge AR, Selsby JT, Zhu Z, Swanson SA, Nella AA, et al. The myopathy of peripheral arterial occlusive disease: Part 1. Functional and histomorphological changes and evidence for mitochondrial dysfunction. Vasc. Endovasc. Surg. 2008;41(6):481–489. doi: 10.1177/1538574407311106. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical